Abstract:Purpose of review: The purpose of this article is to review alterations in microbiota composition, diversity, and functional features in the context of chronic inflammation and comorbidities associated with HIV infection. Recent findings: The gut microbiome is an important mediator of host immunity, and disruption of gut homeostasis can contribute to both systemic inflammation and immune activation. Ageing and HIV share features of intestinal damage, microbial translocation and alterations in bacterial composition that contribute to a proinflammatory state and development of age-related comorbidities. One such inflammatory pathway reviewed is the nicotinamide adenine dinucleotide (NAD+) producing kynurenine pathway (KP). Kynurenine metabolites regulate many biological processes including host-microbiome communication, immunity and oxidative stress and the KP in turn is influenced by the microbiome environment. Age-associated decline in NAD+ is implicated as a driving factor in many age-associated diseases, including those seen in people with HIV (PWH). Recent studies have shown that KP can influence metabolic changes in PWH, including increased abdominal adiposity and cardiovascular disease. Furthermore, KP activity increases with age in the general population, but it is elevated in PWH at all ages compared to age-matched controls. Host or microbiome-mediated targeting of this pathway has merits to increase healthy longevity and has potential therapeutic applications in PWH. Summary: As a growing proportion of PWH age, many face increased risks of developing age-related comorbidities. Chronic inflammation, a pillar of geroscience, the science of ageing and of age-related disease, is influenced by the gut microbiome and its metabolites. Combined, these contribute to a systemic inflammatory signature. Advances in geroscience-based approaches and therapeutics offer a novel paradigm for addressing age-related diseases and chronic inflammation in HIV infection. Whether targeted inhibition of KP activity alleviates pathological conditions or promotes successful ageing in PWH remains to be determined.

What is the collective effect of aging and HIV on the gut microbiome?

Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients

Intestinal Microbiota and Aging in People with HIV—What We Know and What We Don't

Among Older Adults, Age-Related Changes in the Stool Microbiome Differ by HIV-1 Serostatus.

Review on the alteration of gut microbiota: the role of HIV infection and old age.

HIV and comorbidities - the importance of gut inflammation and the kynurenine pathway

Aging With Grace for People Living With HIV: Strategies to Overcome Leaky Gut and Cytomegalovirus Coinfection

Altered Immunity and Microbial Dysbiosis in Aged Individuals With Long-Term Controlled HIV Infection

A Unique Gut Microbiome-Physical Function Axis Exists In Older People With HIV: An Exploratory Study.

Altered gut microbiome composition in HIV infection: causes, effects and potential intervention

HIV and Gut Microbiota: Understanding the Link between Immune Function, Inflammation, and Viral Persistence

Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging

The Gut and the Translocated Microbiomes in HIV Infection: Current Concepts and Future Avenues

Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: an Observational Study in A Chinese Population

Alterations in the Gut Microbiome Composition of People Living with HIV in the Asia-Pacific Region: A Systematic Review

HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration

Alteration of Gut microbiota during HIV infection

The aging gut microbiome and its impact on host immunity

The human gut microbiome and aging

HIV-induced alteration in gut microbiota

Inside Out: HIV, the Gut Microbiome, and the Mucosal Immune System